Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-PINDOLOL | 5MG | TABLET | Resolved | 2021-07-29 | 2021-09-02 | 143265 |
TEVA-OLANZAPINE | 15MG | TABLET | Resolved | 2021-08-05 | 2021-09-09 | 143719 |
TEVA-SILDENAFIL | 50MG | TABLET | Resolved | 2021-08-05 | 2021-08-13 | 143725 |
TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-08-05 | 2021-09-30 | 143728 |
TEVA-CLONIDINE | 0.1MG | TABLET | Resolved | 2021-08-13 | 2021-10-07 | 144108 |
TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2021-08-27 | 2023-06-09 | 144682 |
ACT LEVOFLOXACIN | 500MG | TABLET | Resolved | 2021-08-27 | 2022-01-28 | 144691 |
ACT LEVOFLOXACIN | 750MG | TABLET | Resolved | 2021-08-27 | 2023-06-09 | 144694 |
TEVA-BUPRENORPHINE/NALOXONE | 0.5MG 2MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144704 |
TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144752 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-08-27 | 2021-09-30 | 144760 |
TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2021-08-27 | 2021-10-14 | 144769 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-09-02 | 2021-09-23 | 145112 |
TEVA-ATORVASTATIN | 80MG | TABLET | Resolved | 2021-09-02 | 2021-12-01 | 145115 |
TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2021-09-02 | 2021-09-23 | 145118 |
TEVA-SILDENAFIL | 25MG | TABLET | Resolved | 2021-09-02 | 2021-09-23 | 145121 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-02 | 2022-01-20 | 145124 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Resolved | 2021-09-09 | 2022-03-26 | 145449 |
TEVA-CEPHALEXIN | 500MG | TABLET | Resolved | 2021-09-16 | 2022-04-21 | 145786 |
ACT EXEMESTANE | 25MG | TABLET | Resolved | 2021-09-23 | 2021-11-18 | 146089 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106136 | ||
TEVA-RANITIDINE | Discontinued | 2020-02-13 | 2020-02-13 | 106139 | ||
RATIO-SALBUTAMOL | Discontinued | 2020-02-13 | 2020-02-13 | 106151 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 | ||
EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 |